Perbedaan Multi Indocitra Tbk. dan Charlie Hospital Semarang Tbk.: Multi Indocitra Tbk. diperdagangkan di Rp530 (kapitalisasi pasar 303 M, volume 24 jam 154,1 rb), sedangkan Charlie Hospital Semarang Tbk. diperdagangkan di Rp258 (kapitalisasi pasar 678,4 M, volume 24 jam 25,57 jt). Perbedaan utamanya: Charlie Hospital Semarang Tbk. jauh lebih besar — sekitar 2,2× kapitalisasi pasar Multi Indocitra Tbk., dan Charlie Hospital Semarang Tbk. lebih aktif diperdagangkan (25,57 jt vs 154,1 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MICE | RSCH | |
|---|---|---|
Kapitalisasi Pasar | 303 M | 678,4 M |
Volume | 154,1 rb | 25,57 jt |
Lot | 1,54 rb | 255,67 rb |
Perputaran | 81,24 jt | 6,57 M |
Harga Rata-rata | 527,17 | 256,8 |
Nilai Transaksi | 81,24 jt | 6,57 M |
Harga Ekuilibrium Indikatif | — | 258 |
Volume Ekuilibrium Indikatif | — | 110 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Multi Indocitra Tbk (the Company) was established under its original name of Modern Indocitra based on notarial deed No. 52 of Esther Daniar Iskandar, S.H dated January 11, 1990. The Company's articles of association has been amended several times, the latest amendment dated Aug 16, 2005, regarding the change in the Company's status from private company to public company.
Selengkapnya di halaman MICE →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Selengkapnya di halaman RSCH →